Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
European Journal of Medicinal Chemistry|August 13, 2011
Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptorElena Cichero, Alessia Ligresti, Marco Allarà, et al.
Pharmaceutics|December 23, 2023
New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL AgonistsNaomi Scarano, Francesco Di Palma, Nicola Origlia, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological AssaysAlice Parodi, Giada Righetti, Emanuela Pesce, et al.
European Journal of Medicinal Chemistry|July 8, 2010
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptorsSilvia Franchini, Adolfo Prandi, Annamaria Baraldi, et al.
European Journal of Medicinal Chemistry|September 24, 2020
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assaysAlice Parodi, Giada Righetti, Emanuela Pesce, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological AssaysElena Cichero, Valeria Francesconi, Beatrice Casini, et al.
International Journal of Molecular Sciences|October 26, 2024
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological AssaysFrancesco Piacente, Giorgia Guccione, Naomi Scarano, et al.
European Journal of Medicinal Chemistry|September 28, 2014
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptorsSilvia Franchini, Umberto M Battisti, Annamaria Baraldi, et al.
Bioorganic & Medicinal Chemistry|April 1, 2023
Novel thienocycloalkylpyridazinones as useful scaffolds for acetylcholinesterase inhibition and serotonin 5-HT6 receptor interactionBattistina Asproni, Marco Catto, Giovanni Loriga, et al.
RSC Medicinal Chemistry|July 30, 2026
Probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assaysFrancesca Musumeci, Cecilia Astigiano, Naomi Scarano, et al.
Pageof 9